Transport of polymeric nanoparticle gene carriers in gastric mucus

被引:115
作者
Dawson, M
Krauland, E
Wirtz, D
Hanes, J [1 ]
机构
[1] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA
关键词
D O I
10.1021/bp0342553
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Nanoparticle transport through mucosal barriers is often restricted owing to mucoadhesion and the highly viscoelastic nature of mucus gels, which may limit efficient drug and gene delivery. We formulated sub-200 nm particulates from poly(D,L-lactic-co-glycolic) acid (PLGA) and the cationic surfactant dimethyldioctadecylammonium bromide (DDAB). Subsequently, anionic DNA was condensed to the surface to obtain gene carriers with transfection rates 50-fold higher than those of naked DNA in vitro. Using the method of multiple particle tracking (MPT), we measured the transport rates of dozens of individual PLGA-DDAB/DNA nanoparticles in real time in reconstituted pig gastric mucus (PGM) that possessed physiologically relevant rheological. properties. The average transport rate of PLGA-DDAB/DNA nanoparticles was 10-fold higher than those of similar size polystyrene nanoparticles. Improved transport rates, stability in mucus, and ability to transfect cells make PLGA-DDAB/DNA nanoparticles candidates for mucosal DNA vaccines and gene therapy.
引用
收藏
页码:851 / 857
页数:7
相关论文
共 24 条
[1]  
[Anonymous], PHARM INHALATION AER
[2]   Multiple-particle tracking measurements of heterogeneities in solutions of actin filaments and actin bundles [J].
Apgar, J ;
Tseng, Y ;
Fedorov, E ;
Herwig, MB ;
Almo, SC ;
Wirtz, D .
BIOPHYSICAL JOURNAL, 2000, 79 (02) :1095-1106
[3]  
Cone R., 1999, MUCOSAL IMMUNOLOGY, P43
[4]   Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport [J].
Dawson, M ;
Wirtz, D ;
Hanes, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) :50393-50401
[5]   Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells [J].
Denis-Mize, KS ;
Dupuis, M ;
MacKichan, ML ;
Singh, M ;
Doe, B ;
O'Hagan, D ;
Ulmer, JB ;
Donnelly, JJ ;
McDonald, DM ;
Ott, G .
GENE THERAPY, 2000, 7 (24) :2105-2112
[6]   Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium [J].
Ferrari, S ;
Kitson, C ;
Farley, R ;
Steel, R ;
Marriott, C ;
Parkins, DA ;
Scarpa, M ;
Wainwright, B ;
Evans, MJ ;
Colledge, WH ;
Geddes, DM ;
Alton, EWFW .
GENE THERAPY, 2001, 8 (18) :1380-1386
[7]   Drug transfer through mucus [J].
Khanvilkar, K ;
Donovan, MD ;
Flanagan, DR .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 48 (2-3) :173-193
[8]   Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection [J].
Kumar, M ;
Behera, AK ;
Lockey, RF ;
Zhang, J ;
Bhullar, G ;
De La Cruz, CP ;
Chen, LC ;
Leong, KW ;
Huang, SK ;
Mohapatra, SS .
HUMAN GENE THERAPY, 2002, 13 (12) :1415-1425
[9]  
MCGHEE JR, 1999, MUCOSAL IMMUNOLOGY, P485
[10]  
Miller J., 1972, EXPT MOL GENETICS